マルチモーダルイメージングの世界市場予測（～2024年）...市場調査レポートについてご紹介

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Markets Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 18)
2.1 Secondary and Primary Research Methodology
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions and Limitations
2.4.1 Assumptions for the Study
2.4.2 Limitations
3 Executive Summary (Page No. – 29)
4 Premium Insights (Page No. – 33)
4.1 Multimodal Imaging: Market Overview
4.2 Geographic Analysis: Multimodal Imaging Market Share, By Application and Region, 2018
4.3 Technology Analysis: Market Size, 2019 vs 2024 (USD Million)
4.4 End-User Analysis: Market Share, 2019 vs 2024
4.5 Geographic Snapshot of the Market
5 Market Overview (Page No. – 37)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Applications of Multimodal Imaging Systems
5.2.1.2 Technological Advancements in Diagnostic Imaging Modalities
5.2.1.3 Availability of Funding for Research
5.2.2 Restraints
5.2.2.1 High Cost of Multimodal Imaging Systems
5.2.2.2 Lack of Adequate Healthcare Infrastructure
5.2.3 Opportunities
5.2.3.1 Availability of Reimbursement and Insurance Coverage for Scans
5.2.3.2 Increasing R&D Into Radiotracers
5.2.4 Challenges
5.2.4.1 Dearth of Trained Professionals
6 Multimodal Imaging Market, By Technology (Page No. – 44)
6.1 Introduction
6.2 PET/CT Systems
6.2.1 PET/CT Systems Have Almost Practically Replaced Stand-Alone PET Systems Across the World
6.2.2 PET/CT Systems Market Split By Application, 2017–2024 (USD Million)
6.2.3 PET/CT Systems Market Split By End User, 2017–2024 (USD Million)
6.3 SPECT/CT Systems
6.3.1 Improved Resolution of SPECT/CT Systems has Provided A Clear Advantage Over Stand-Alone Spect Systems
6.3.2 SPECT/CT Systems Market Split By Application, 2017–2024 (USD Million)
6.3.3 SPECT/CT Systems Market Split By End User, 2017–2024 (USD Million)
6.4 PET/MR Systems
6.4.1 PET/MR Systems Showcase Increasing Clinical Evidence With Enhanced Tissue Contrast
6.4.2 PET/MR Systems Market Split By Application, 2017–2024 (USD Million)
6.4.3 PET/MR Systems Market Split By End User, 2017–2024 (USD Million)
6.5 OCT/Fundus Imaging Systems
6.5.1 OCT/Fundus Imaging Systems Have Wide Applications in Retinal Disease Diagnosis
6.5.2 OCT/Fundus Imaging Systems Market Split By Application, 2017–2024 (USD Million)
6.5.3 OCT/Fundus Imaging Systems Market Split By End User, 2017–2024 (USD Million)
6.6 Other Multimodal Imaging Systems
6.6.1 Other Multimodal Imaging Systems Market Split By Application, 2017–2024 (USD Million)
6.6.2 Other Multimodal Imaging Systems Market Split By End User, 2017–2024 (USD Million)
7 Multimodal Imaging Market, By Application (Page No. – 57)
7.1 Introduction
7.2 Oncology
7.2.1 Oncology is the Largest Application Segment of the Market
7.3 Ophthalmology
7.3.1 Technological Innovations in Ophthalmic Multimodal Imaging Systems By Key Market Players to Support Market Growth
7.4 Cardiology
7.4.1 Increasing Prevalence of Cardiac Conditions & Increasing Demand for Early Disease Diagnosis to Support Market Growth
7.5 Brain & Neurology
7.5.1 Increasing Incidence of Brain & Neurological Disorders to Propel the Adoption of Multimodal Imaging Systems
7.6 Other Applications
8 Multimodal Imaging Market, By End User (Page No. – 65)
8.1 Introduction
8.2 Hospitals
8.2.1 Large Hospitals With Nuclear Medicine Departments Have Been Early Adopters of Multimodal Imaging Systems
8.3 Diagnostic Imaging Centers
8.3.1 Increasing Number of Private Imaging Centers is Contributing to the Growth of This Segment
8.4 Other End Users
9 Multimodal Imaging Market, By Region (Page No. – 72)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Dominates the North American Market
9.2.2 Canada
9.2.2.1 Government Budget Cuts and Long Wait Time for Scans to Hamper the Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Favorable Reimbursement Scenario in the Country to Support Market Growth
9.3.2 UK
9.3.2.1 Government Initiatives and the Increasing Number of Funding and Research Activities Related to the Use of Multimodal Imaging are Driving Market Growth
9.3.3 France
9.3.3.1 France has the Third-Largest Government Expenditure on Healthcare—A Major Factor Driving Market Growth
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Large Installation Base of Hybrid Imaging Systems – A Major Factor Driving Market Growth
9.4.2 China
9.4.2.1 China to Witness the Highest Growth Rate in the Global Market During the Forecast Period
9.4.3 India
9.4.3.1 Lack of Reimbursement for Diagnostic Imaging Procedures to Hamper Market Growth
9.4.4 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.1.1 Brazil Dominates the Latin American Market Due to the High Burden of Cancer
9.5.2 Mexico
9.5.2.1 Rising Incidence of Cancer to Drive Market Growth in Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Improved Healthcare Infrastructure and Growing Awareness of Multimodal Imaging are Driving Market Growth in the Mea
10 Competitive Landscape (Page No. – 101)
10.1 Introduction
10.2 Market Share Analysis, 2018
10.3 Competitive Situation and Trends
10.4 Competitive Leadership Mapping
10.5 Vendor Inclusion Criteria
10.6 Vendor Dive
10.6.1 Visionary Leaders
10.6.2 Innovators
10.6.3 Dynamic Differentiators
10.6.4 Emerging Players
11 Company Profiles (Page No. – 107)
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 Canon, Inc.
11.2 GE Healthcare
11.3 Heidelberg Engineering
11.4 Infraredx, Inc. (A Part of Nipro Corporation)
11.5 Koninklijke Philips N.V.
11.6 Mediso Medical Imaging Systems Kft
11.7 Neusoft Medical Systems Co., Ltd
11.8 Siemens Healthineers
11.9 Spectrum Dynamics Medical
11.10 Topcon Corporation
11.11 United Imaging Healthcare Co., Ltd.
11.12 Zeiss Group
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 131)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details